Brain abscess: pathophysiology, diagnosis, and management – a single centre prospective study

Authors

DOI:

https://doi.org/10.67667/NEU.v27i2.219

Abstract

Background: Brain abscess is a life-threatening intracranial infection, typically caused by contiguous spread (e.g., sinusitis) or hematogenous seeding (e.g., endocarditis), and is more common in males and in developing countries, with peak incidence in the first two decades of life. Symptoms include headache, fever, altered mental status, nausea/vomiting, seizures (25–34%), and focal neurological deficits. It progresses through four stages over 2–4 weeks, culminating in capsule formation. Diagnosis is best achieved with MRI (especially DWI and ¹H-MRS), which differentiates abscesses from tumors, while CT supports localization and monitoring. Treatment involves ≥6 weeks of BBB-penetrating antibiotics and surgery—stereotactic aspiration for abscesses >2.5 cm, or excision for complex cases. Corticosteroids are used cautiously; anticonvulsants may be continued long-term. With prompt combined therapy, cure rates exceed 90%. Close imaging follow-up is essential to detect complications. This study highlights significant variability in presentation, pathology, management, and outcomes among surgical patients.

Methods: This prospective study analyzed 17 patients with brain abscess treated surgically at the Department of Neurosurgery, SVP Hospital and SMT. NHL Medical College, Ahmedabad, between January 2022 and August 2025. Inclusion required microbiological/histopathological confirmation of infection, characteristic MRI/CT findings, and lesion resolution with antibiotics; cases due to postoperative complications or meningioencephalitis were excluded. All patients underwent baseline and serial CT scans to evaluate abscess size, wall morphology, and perifocal edema. Abscesses ≥2 cm were managed surgically—predominantly via craniotomy and excision—while those <2 cm received medical therapy alone. Empirical broad-spectrum intravenous antibiotics were initiated immediately, adjusted based on culture and sensitivity, and continued for six weeks. Adjunctive corticosteroids were given under antibiotic cover and tapered over four weeks. Postoperative CT was performed within 24 hours, followed by imaging at 1, 3, and 6 months. Clinical outcomes were assessed using the modified Rankin Scale. The study underscores a standardized, multimodal approach to brain abscess management with favorable outcomes.

Results: This prospective study analyzed 17 brain abscess patients (8 males, 9 females; median age 29 years) treated at SVP Hospital, Ahmedabad (Jan 2022–Aug 2025). Most common symptoms were fever/meningeal signs (11), seizures (5), headache (5), and neurological deficits (6). Temporo-parietal location predominated (11 cases); mean abscess size was 4.5 cm. Sixteen underwent craniotomy with excision; one had aspiration. All received 6 weeks of IV antibiotics (adjusted per culture) and a 4-week steroid taper. Causative organisms were identified in 10 cases (Staphylococcus spp., Streptococcus, M. tuberculosis, Aspergillus, hydatid cyst); 6 were culture-negative. Complications included ventriculitis with hydrocephalus (1), managed with ventriculostomy ± VP shunt. At 6 months, 88.23% had good outcomes (mRS 0–2); 2 patients died (one with congenital heart disease and altered sensorium, the other from meningitis/encephalitis). No recurrences occurred. Early diagnosis, surgical excision, and prompt antimicrobial therapy significantly predicted favorable outcomes (p < 0.001).

Conclusion: CNS infections remain life-threatening, demanding urgent multimodal care. Pyogenic brain abscesses >2 cm require emergent surgery—usually burr-hole aspiration; craniotomy is reserved for complex cases. Prolonged (≥6 weeks) IV antibiotics prevent relapse. Despite challenges like diagnostic delays and antimicrobial resistance, outcomes have improved with advanced diagnostics, targeted therapy, and neurocritical care. Timely treatment yields excellent recovery. Reducing the global burden requires equitable access, innovation, and a holistic approach spanning prevention to rehabilitation.

References

1. Sharma BS, Gupta SK, Khosla VK. Current concepts in the management of pyogenic brain abscess. Neurol India 2000;48:105e11.

2. Menon S, Bharadwaj R, Chowdhary A, Kaundinya DV, Palande DA. Current epidemiology of intracranial abscesses: a prospective 5 year study. J Med Microbiol 2008;57:1259–68. DOI: https://doi.org/10.1099/jmm.0.47814-0

3. Carpenter J, Stapleton S, Holliman R. Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis 2007;26:1e11. DOI: https://doi.org/10.1007/s10096-006-0236-6

4. Hakan T, Ceran N, Erdem I, Berkman MZ, Göktas¸ P. Bacterial brain abscesses: an evaluation of 96 cases. J Infect 2006;52:359e66. DOI: https://doi.org/10.1016/j.jinf.2005.07.019

5. Ersin E, Tufan C. Pyogenic brain abscess. Neurosurg Focus 2008;24(E2):1e10. DOI: https://doi.org/10.3171/FOC/2008/24/6/E2

6. Salzman C, Tuazon CU. Value of the ring-enhancing sign in differentiating intracerebral hematomas and brain abscesses. Arch Intern Med 1987;147: 951e2. DOI: https://doi.org/10.1001/archinte.1987.00370050143024

7. Guzman R, Barth A, Lövblad KO, El-Koussy M, Weis J, Schroth, et al. Use of diffusion weighted magnetic resonance imaging in differentiating purulent brain processes from cystic brain tumors. J Neurosurg 2002;97:1101–7. DOI: https://doi.org/10.3171/jns.2002.97.5.1101

8. Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson 3rd HF, Johnston KW, et al. In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 2000;74:83–94. DOI: https://doi.org/10.1159/000056467

9. de Louvois J. Bacteriological examination of pus from abscess of the central nervous system. J Clin Pathol 1980;33:66e71. DOI: https://doi.org/10.1136/jcp.33.1.66

10. Legg NJ, Gupta PC, Scott DF. Epilepsy following cerebral abscess. A clinical and EEG study of 70 patients. Brain 1973;96:259e68. DOI: https://doi.org/10.1093/brain/96.2.259

11. Ng PY, Seow WT, Ong PL. Brain abscesses: review of 30 cases treated with surgery. Aust N Z J Surg 1995;65:664e6. DOI: https://doi.org/10.1111/j.1445-2197.1995.tb00677.x

12. Mamelak AN, Mampalam TJ, Obana WG, Rosenblum ML. Improved management of multiple brain abscesses: a combined surgical and medical approach.Neurosurgery 1995;36:76e86. DOI: https://doi.org/10.1097/00006123-199501000-00010

13. Clark CA, Barrick TR, Murphy MM, Bell BA. White matter fiber tracking in patients with space-occupying lesions of the brain: a new technique for neuro- surgical planning? Neuroimage 2003;20:1601–8. DOI: https://doi.org/10.1016/j.neuroimage.2003.07.022

14. Yang SY, Zhao CS. Review of 140 patients with brain abscess. Surg Neurol 1993;39:290e6. DOI: https://doi.org/10.1016/0090-3019(93)90008-O

15. Zhang C, Hu L, Wu X, Hu G, Ding X, Lu Y. A retrospective study on the aetiology, management, and outcome of brain abscess in an 11-year, single-centre study from China. BMC Infect Dis. 2014;14:311. DOI: https://doi.org/10.1186/1471-2334-14-311

16. Prusty GK. Brain abscesses in cyanotic heart disease. Indian J Pediatr 1993;60: 43e53. DOI: https://doi.org/10.1007/BF02860506

17. Moorthy RK, Rajshekhar V. Management of brain abscess: an overview. Neurosurg Focus. 2008;24(6):E3. DOI: https://doi.org/10.3171/FOC/2008/24/6/E3

18. Manzar N, Manzar B, Kumar R, Bari ME. The study of etiologic and demographic characteristics of intracranial brain abscess: a consecutive case series study from Pakistan. World Neurosurg. 2011;76(1–2):195–200. DOI: https://doi.org/10.1016/j.wneu.2011.02.011

19. Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology.2014;82(9):806–13. DOI: https://doi.org/10.1212/WNL.0000000000000172

20. Desai K, Bhatjiwale M, Nadkarni T, Goel A. Flare up of tuberculous abscess following stereotactic aspiration. Case report. Neurologia Medico-Chirurgica 2002;42:147–9. DOI: https://doi.org/10.2176/nmc.42.147

21. Li Q, You C, Liu Q, Liu Y. Central nervous system cryptococcoma in immunocompetent patients: a short review illustrated by a new case. Acta Neurochir (Wien) 2010;152:129–36. DOI: https://doi.org/10.1007/s00701-009-0311-8

22. Limaiem F, Bellil S, Bellil K, Chelly I, Mekni A, Khaldi M, et al. Primary hydatidosis of the central nervous system: a retrospective study of 39 Tunisian cases. Clin Neurol Neurosurg 2010;112:23–8. DOI: https://doi.org/10.1016/j.clineuro.2009.09.001

23. Cavuşoglu H, Kaya RA, Türkmenoglu ON, Colak I, Aydin Y. Brain abscess: analysis of results in a series of 51 patients with a combined surgical and medical approach during an 11-year period. Neurosurg Focus. 2008;24(6):E9. DOI: https://doi.org/10.3171/FOC/2008/24/6/E9

24. Xiao F, Tseng MY, Teng LJ, Tseng HM, Tsai JC. Brain abscess clinical experience and analysis of prognostic factors. Surg Neurol. 2005;63(5):442–9. DOI: https://doi.org/10.1016/j.surneu.2004.08.093

25. Lange N, Berndt M, Jörger AK, Wagner A, Wantia N, Lummel N, Ryang YM, Meyer B, Gempt J. Clinical characteristics and course of primary brain abscess. Acta Neurochir. 2018;160(10):2055–62. DOI: https://doi.org/10.1007/s00701-018-3633-6

Downloads

Published

28.08.2026

How to Cite

Padshala, R., Imam, N., Shah, V., Soladhra, K., Velani, D., Shah, K., … Vala, K. (2026). Brain abscess: pathophysiology, diagnosis, and management – a single centre prospective study. Bulgarian Neurology, 27(2), 43–50. https://doi.org/10.67667/NEU.v27i2.219

Issue

Section

ORIGINAL PAPERS

ARK